JP2020516313A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020516313A5 JP2020516313A5 JP2020504441A JP2020504441A JP2020516313A5 JP 2020516313 A5 JP2020516313 A5 JP 2020516313A5 JP 2020504441 A JP2020504441 A JP 2020504441A JP 2020504441 A JP2020504441 A JP 2020504441A JP 2020516313 A5 JP2020516313 A5 JP 2020516313A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutically acceptable
- acceptable salt
- peptide
- cancer
- cell receptor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762483690P | 2017-04-10 | 2017-04-10 | |
| US62/483,690 | 2017-04-10 | ||
| DE102017107710 | 2017-04-10 | ||
| DE102017107710.3 | 2017-04-10 | ||
| PCT/EP2018/059114 WO2018189152A2 (en) | 2017-04-10 | 2018-04-10 | Peptides and combination of peptides for use in immunotherapy against leukemias and other cancers |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020516313A JP2020516313A (ja) | 2020-06-11 |
| JP2020516313A5 true JP2020516313A5 (https=) | 2021-08-05 |
| JP7026970B2 JP7026970B2 (ja) | 2022-03-01 |
Family
ID=62116820
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020504441A Expired - Fee Related JP7026970B2 (ja) | 2017-04-10 | 2018-04-10 | 白血病およびその他のがんに対する免疫療法において使用するためのペプチドおよびペプチドの組み合わせ |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US20220118016A1 (https=) |
| EP (1) | EP3609531A2 (https=) |
| JP (1) | JP7026970B2 (https=) |
| KR (1) | KR20190137858A (https=) |
| CN (3) | CN110944660A (https=) |
| AU (1) | AU2018253341B2 (https=) |
| BR (1) | BR112019021094A2 (https=) |
| CA (1) | CA3059645A1 (https=) |
| CL (7) | CL2019002878A1 (https=) |
| CO (1) | CO2019012071A2 (https=) |
| CR (1) | CR20190509A (https=) |
| IL (1) | IL269813A (https=) |
| MA (1) | MA49123A (https=) |
| MX (1) | MX2019012226A (https=) |
| MY (1) | MY197772A (https=) |
| PE (1) | PE20191617A1 (https=) |
| PH (1) | PH12019502300A1 (https=) |
| SG (3) | SG11201909058WA (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015084897A2 (en) * | 2013-12-02 | 2015-06-11 | Mirimmune, Llc | Immunotherapy of cancer |
| WO2018140573A1 (en) * | 2017-01-26 | 2018-08-02 | Sangamo Therapeutics, Inc. | B-cell engineering |
| CR20200059A (es) * | 2017-07-07 | 2020-06-01 | Immatics Biotechnologies Gmbh | Nuevos péptidos y nuevas combinaciones de péptidos para el uso en la inmunoterapia contra el cáncer de pulmón, incluyendo el nsclc, el sclc y otros cánceres |
| CN113109564A (zh) * | 2021-03-15 | 2021-07-13 | 成都益安博生物技术有限公司 | 一种急性髓细胞性白血病的外周血tcr标志物及其检测试剂盒和应用 |
| CN117586344B (zh) * | 2022-08-12 | 2025-07-25 | 上海交通大学医学院附属瑞金医院 | 靶向flt3-d835突变的抗原肽及其在肿瘤免疫治疗中的应用 |
| CN117552115B (zh) * | 2024-01-12 | 2024-03-26 | 天津鲸鹏生物科技有限责任公司 | 用于诱导肿瘤特异性免疫响应的通用型抗原肽库及其应用 |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040005561A1 (en) * | 2000-03-01 | 2004-01-08 | Corixa Corporation | Compositions and methods for the detection, diagnosis and therapy of hematological malignancies |
| US20030148321A1 (en) | 2001-08-24 | 2003-08-07 | Iris Pecker | Methods and kits for diagnosing and monitoring hematopoietic cancers |
| US8039218B2 (en) | 2002-11-14 | 2011-10-18 | John Wayne Cancer Institute | Detection of cancer cells in body fluids |
| EP1640452A4 (en) | 2003-05-30 | 2009-12-23 | Nippon Shinyaku Co Ltd | OLIGOBICATENARY RNA INHIBITING BCL-2 EXPRESSION AND MEDICINAL COMPOSITION CONTAINING THE SAME |
| WO2006113747A2 (en) | 2005-04-19 | 2006-10-26 | Prediction Sciences Llc | Diagnostic markers of breast cancer treatment and progression and methods of use thereof |
| US20080280297A1 (en) | 2005-07-15 | 2008-11-13 | The Trustees Of Columbia University In The City Of | Compositions and Methods for Differential Diagnosis of Chronic Lymphocytic Leukemia |
| ES2341802T3 (es) | 2005-09-05 | 2010-06-28 | Immatics Biotechnologies Gmbh | Peptidos asociados a tumores unidos promiscuamente a moleculas del antigeno de leucocito humano (hla) de clase ii. |
| WO2007064743A2 (en) * | 2005-11-30 | 2007-06-07 | Cell Signaling Technology, Inc. | Reagents for the detection of protein phosphorylation in leukemia signaling pathways |
| WO2008103905A2 (en) | 2007-02-23 | 2008-08-28 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Antibodies that specifically bind irta and methods of use |
| EA018457B1 (ru) * | 2007-07-27 | 2013-08-30 | Имматикс Байотекнолоджиз Гмбх | Композиция опухолеассоциированных пептидов и относящаяся к ним противораковая вакцина |
| GB0721686D0 (en) * | 2007-11-05 | 2007-12-12 | Medinnova As | Polypeptides |
| US20110190157A1 (en) | 2008-08-15 | 2011-08-04 | The Regents Of The University Of California | Biomarkers for Diagnosis and Treatment of Chronic Lymphocytic Leukemia |
| WO2010106535A1 (en) | 2009-03-15 | 2010-09-23 | Technion Research And Development Foundation Ltd. | Soluble hla complexes for use in disease diagnosis |
| US20120178111A1 (en) | 2009-09-23 | 2012-07-12 | Diamandis Eleftherios P | Methods and compositions for the detection of lung cancers |
| WO2014180490A1 (en) | 2013-05-10 | 2014-11-13 | Biontech Ag | Predicting immunogenicity of t cell epitopes |
| TWI775117B (zh) * | 2013-08-05 | 2022-08-21 | 德商伊瑪提克斯生物科技有限公司 | 新穎肽類，細胞及其用於治療多種腫瘤的用途，其製造方法及包含其等之醫藥組成物（二） |
| GB201319446D0 (en) | 2013-11-04 | 2013-12-18 | Immatics Biotechnologies Gmbh | Personalized immunotherapy against several neuronal and brain tumors |
| GB201408255D0 (en) | 2014-05-09 | 2014-06-25 | Immatics Biotechnologies Gmbh | Novel immunotherapy against several tumours of the blood, such as acute myeloid leukemia (AML) |
| GB201411037D0 (en) | 2014-06-20 | 2014-08-06 | Immatics Biotechnologies Gmbh | Novel immunotherapy against several tumors of the blood, in particular chronic lymphoid leukemai (CLL) |
| GB201507030D0 (en) | 2015-04-24 | 2015-06-10 | Immatics Biotechnologies Gmbh | Immunotherapy against lung cancers, in particular NSCLC |
| GB201511191D0 (en) | 2015-06-25 | 2015-08-12 | Immatics Biotechnologies Gmbh | T-cell epitopes for the immunotherapy of myeloma |
| GB201515321D0 (en) | 2015-08-28 | 2015-10-14 | Immatics Biotechnologies Gmbh | Novel peptides, combination of peptides and scaffolds for use in immunotherapeutic treatment of various cancers |
| GB201521746D0 (en) | 2015-12-10 | 2016-01-27 | Immatics Biotechnologies Gmbh | Novel peptides and combination of peptides for use in immunotherapy against CLL and other cancers |
| GB201521894D0 (en) | 2015-12-11 | 2016-01-27 | Immatics Biotechnologies Gmbh | Novel peptides and combination of peptides for use in immunotherapy against various cancers |
-
2018
- 2018-04-10 MY MYPI2019005841A patent/MY197772A/en unknown
- 2018-04-10 JP JP2020504441A patent/JP7026970B2/ja not_active Expired - Fee Related
- 2018-04-10 CA CA3059645A patent/CA3059645A1/en active Pending
- 2018-04-10 MA MA049123A patent/MA49123A/fr unknown
- 2018-04-10 BR BR112019021094-6A patent/BR112019021094A2/pt not_active IP Right Cessation
- 2018-04-10 CR CR20190509A patent/CR20190509A/es unknown
- 2018-04-10 CN CN201880023853.3A patent/CN110944660A/zh active Pending
- 2018-04-10 EP EP18722907.5A patent/EP3609531A2/en not_active Withdrawn
- 2018-04-10 KR KR1020197032832A patent/KR20190137858A/ko not_active Withdrawn
- 2018-04-10 CN CN202010276749.4A patent/CN111533799A/zh active Pending
- 2018-04-10 SG SG11201909058W patent/SG11201909058WA/en unknown
- 2018-04-10 SG SG10202100326SA patent/SG10202100326SA/en unknown
- 2018-04-10 AU AU2018253341A patent/AU2018253341B2/en not_active Ceased
- 2018-04-10 MX MX2019012226A patent/MX2019012226A/es unknown
- 2018-04-10 SG SG10202100324YA patent/SG10202100324YA/en unknown
- 2018-04-10 PE PE2019001977A patent/PE20191617A1/es unknown
- 2018-04-10 CN CN202011264405.8A patent/CN112521478A/zh active Pending
-
2019
- 2019-10-03 IL IL26981319A patent/IL269813A/en unknown
- 2019-10-07 PH PH12019502300A patent/PH12019502300A1/en unknown
- 2019-10-09 CL CL2019002878A patent/CL2019002878A1/es unknown
- 2019-10-29 CO CONC2019/0012071A patent/CO2019012071A2/es unknown
-
2020
- 2020-11-13 CL CL2020002949A patent/CL2020002949A1/es unknown
- 2020-11-13 CL CL2020002951A patent/CL2020002951A1/es unknown
- 2020-11-13 CL CL2020002952A patent/CL2020002952A1/es unknown
- 2020-11-13 CL CL2020002948A patent/CL2020002948A1/es unknown
- 2020-11-13 CL CL2020002953A patent/CL2020002953A1/es unknown
- 2020-11-13 CL CL2020002950A patent/CL2020002950A1/es unknown
-
2021
- 2021-06-23 US US17/356,174 patent/US20220118016A1/en not_active Abandoned
-
2022
- 2022-06-17 US US17/843,412 patent/US11559550B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020516313A5 (https=) | ||
| JP7542870B2 (ja) | 免疫療法のためのナノ粒子組成物及び方法 | |
| JP2020191862A5 (https=) | ||
| JP2019515650A5 (https=) | ||
| JP2020516681A5 (https=) | ||
| JP2019536426A5 (https=) | ||
| HRP20202019T1 (hr) | Novi peptidi i kombinacija peptida za uporabu u imunoterapiji protiv raka jajnika i drugih malignih tumora | |
| JP2019513005A5 (https=) | ||
| JP2020506690A5 (https=) | ||
| JP2019515653A5 (https=) | ||
| HRP20210709T1 (hr) | Peptidi i kombinacija peptida za imunoterapiju protiv karcinoma prostate i druge vrste karcinoma | |
| JP2019520038A5 (https=) | ||
| HRP20201281T1 (hr) | Novi peptidi i kombinacija peptida za uporabu u imunoterapiji protiv epitelnog karcinoma jajnika i drugih karcinoma | |
| JP6566938B2 (ja) | 免疫療法のための組成物及び方法 | |
| CN112654346B (zh) | 生物分子包覆颗粒和薄膜及其用途 | |
| JP2021535900A5 (https=) | ||
| JP2021528046A5 (https=) | ||
| HRP20230878T1 (hr) | Novi peptidi i kombinacija peptida za uporabu u imunoterapiji protiv raznih karcinoma (seq id 25 - mrax5-003) | |
| JP2022502015A5 (https=) | ||
| JP2021522779A5 (https=) | ||
| JP2020191868A5 (https=) | ||
| JP2021045150A5 (https=) | ||
| HRP20191671T1 (hr) | Nova imunoterapija za liječenje nekoliko tumora krvi, kao što je akutna mijeloidna leukemija (aml) | |
| JPWO2021092436A5 (https=) | ||
| HRP20211327T1 (hr) | Novi peptidi i kombinacije peptida za upotrebu u imunoterapiji protiv hepatocelularnog karcinoma (hcc) i drugih rakova |